If PD-1 blockade might induce IL-10 secretion by innate immune cells, as described in the previous section, and a parallel upregulation of IL-10R on T cells, these two combined events might cause severe dampening of CD8+ T cell antitumor activity, favoring tumor growth. Here, IL10 is linked to neoplasm.